EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Writing the Signs: An Explainable Machine Learning Approach for Alzheimer's Disease Classification from Handwriting

Ngoc Truc Ngan Ho, Paulina Gonzalez, Gideon K. Gogovi

Healthcare Technology Letters · 2025-01 · 12 (1)

DOI: 10.1049/htl2.70006 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Alzheimer's disease is a global health challenge, emphasizing the need for early detection to enable timely intervention and improve outcomes. This study analyzes handwriting data from individuals with and without Alzheimer's to identify predictive features across copying, graphic and memory‐based tasks. Machine learning models, including Random Forest, Bootstrap Aggregating (Bagging), Extreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), Adaptive Boosting (AdaBoost) and Gradient Boosting, were applied to classify patients, with SHapley Additive exPlanations (SHAP) enhancing model interpretability. Time‐related features were crucial in copying and graphic tasks, reflecting cognitive processing speed, while pressure‐related features were significant in memory tasks, indicating recall confidence. Simpler graphic tasks showed strong discriminatory power, aiding early detection. Performance metrics demonstrated model effectiveness: For memory tasks, Random Forest achieved the highest accuracy (), while Bagged SVC was the lowest (). Copying tasks recorded a peak accuracy of with Gradient Boost and a low of for Bagged SVC. Graphic tasks reached with Gradient Boost and 0.643 ± 0.071 with AdaBoost. For all tasks combined, Random Forest excelled (), while Gradient Boost performed worst (). These results highlight handwriting analysis's potential in Alzheimer's detection.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →